本品为白色固体，纯度大于99%，少量现货售完即止
化合物简介
SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. It is currently undergoing Phase-III clinical trials for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients.
基本信息
- 中文名称：
- 沃拉帕沙硫酸盐
- 中文别名：
- 硫酸沃拉帕沙
- 英文名称：
- Vorapaxar sulfate
- 英文别名：
- ethyl N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f][2]benzofuran-6-yl]carbamate,sulfuric acid;
ethyl ((1R,3aR,4aR,6R,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate sulfate;
Sch 530348;
- CAS号：
- 705260-08-8
- 分子式：
- C29H35FN2O8S
- 分子量：
- 590.66000
- 精确质量：
- 590.21000
- PSA：
- 160.50000
- LogP：
- 6.44840
